ICLR · NASDAQ · Medical - Diagnostics & Research

ICON

Runs outsourced clinical development programs for drug and medical-device makers worldwide.

$170.02
After-hours close+0.12 (+0.07%)
At close$169.90(+0.11%)

Breakdown13F · Form 4

Institutions 104.97%Insiders 0.54%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 76.57M · Float 75.85M · 99.1% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Artisan Partners Limited Partnership8.64M11.28%13FAug 13, 2026
Wellington Management Group LLP5.32M6.95%13FAug 14, 2026
FMR LLC5.27M6.88%13FAug 13, 2026
Invesco Ltd.5.26M6.88%13FAug 14, 2026
Harris Associates L P4.47M5.84%13FAug 14, 2026

Institutions13F, as of Jun 30, 2026

448 holders · 80.37M shares · 89 new positions · 238 increased · 139 reduced · 85 closed

HolderShares% outstandingChg q/qFiled
Artisan Partners Limited Partnership8.64M11.28%+357.5KAug 13, 2026
Wellington Management Group LLP5.32M6.95%−593.0KAug 14, 2026
FMR LLC5.27M6.88%+1.10MAug 13, 2026
Invesco Ltd.5.26M6.88%+1.39MAug 14, 2026
Harris Associates L P4.47M5.84%+116.8KAug 14, 2026
Brave Warrior Advisors, LLC3.15M4.12%+156.5KAug 14, 2026
Greenhaven Associates Inc3.10M4.05%+1.10MJul 28, 2026
Principal Financial Group Inc2.95M3.85%−360.8KAug 4, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Artisan Partners Asset Management Inc.10.90%8.36M13GMar 6, 2026
Wellington Management Group LLP7.70%5.91M13GMay 15, 2026
Harris Associates L P5.70%4.35M13GMay 15, 2026
FMR LLC5.50%4.17M13GMay 6, 2026
Invesco Ltd.5.10%3.88M13GMay 6, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
John Dr Climaxdirector287.2K0.38%Aug 12, 2026
Stephen A. Cutlerdirector79.3K0.10%Mar 18, 2026
Ciaran Murraydirector20.5K0.03%Aug 12, 2026
Linda Graisdirector6.2K0.01%Aug 12, 2026
Nigel Bernard John Clerkinofficer: Chief Financial Officer5.9K0.01%Aug 12, 2026
Barry Edward Balfedirector, officer: Chief Executive Officer4.8K0.01%Aug 11, 2026
Ronan Martin Murphydirector3.8K0.01%Aug 12, 2026
Eugene Pacelli McCaguedirector3.8K0.00%Aug 12, 2026
Julie O'Neilldirector3.5K0.00%Aug 12, 2026
Anne Clem Whitakerdirector8910.00%Aug 12, 2026

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 11, 2026
Ronan Martin Murphydirector
Sale · 4 lots841$164.293,847
Aug 11, 2026
Ciaran Murraydirector
Sale · 4 lots2,677$164.2920,452
Aug 11, 2026
Julie O'Neilldirector
Sale · 4 lots915$164.293,515
Aug 11, 2026
Anne Clem Whitakerdirector
Sale · 4 lots841$164.29891
Aug 11, 2026
Eugene Pacelli McCaguedirector
Sale · 4 lots841$164.293,811
Aug 11, 2026
Nigel Bernard John Clerkinofficer: Chief Financial Officer
Sale · 4 lots2,267$164.295,881
Aug 11, 2026
John Dr Climaxdirector
Sale · 4 lots841$164.292,087
Aug 11, 2026
Linda Graisdirector
Sale · 4 lots841$164.296,162
Aug 10, 2026
Barry Edward Balfedirector, officer: Chief Executive Officer
Sale · 2 lots382$164.074,804

CongressHouse and Senate disclosures

Not reported.